NewEdge Advisors LLC Buys 8,142 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• NewEdge Advisors increased its Intuitive Surgical stake by 19.1% in the second quarter, purchasing 8,142 shares and bringing its holdings to 50,825 shares valued at approximately $20.2 million. Institutional investors collectively own 83.64% of the company.
• Analysts maintain a favorable outlook, with 22 Buy ratings, eight Holds and one Sell, producing a consensus “Moderate Buy” rating and a $508.68 target price. However, several firms recently lowered their targets as ISRG shares traded at $360.46, well below their 52-week high.
• Intuitive Surgical exceeded quarterly expectations with $2.80 in earnings per share and $2.89 billion in revenue, up 18.4% year over year. Insiders have nevertheless sold 11,256 shares worth about $4.5 million over the past three months, while investors continue to monitor procedure growth, competition and cost pressures.

NewEdge Advisors LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 19.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 50,825 shares of the medical equipment provider's stock after buying an additional 8,142 shares during the period. NewEdge Advisors LLC's holdings in Intuitive Surgical were worth $20,212,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Prosperity Consulting Group LLC increased its stake in Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider's stock worth $1,804,000 after purchasing an additional 19 shares during the period. Dana Investment Advisors Inc. grew its holdings in shares of Intuitive Surgical by 1.9% in the fourth quarter. Dana Investment Advisors Inc. now owns 1,140 shares of the medical equipment provider's stock worth $646,000 after purchasing an additional 21 shares during the last quarter. Forefront Wealth Partners LLC grew its holdings in shares of Intuitive Surgical by 2.6% in the fourth quarter. Forefront Wealth Partners LLC now owns 819 shares of the medical equipment provider's stock worth $464,000 after purchasing an additional 21 shares during the last quarter. High Note Wealth LLC increased its stake in shares of Intuitive Surgical by 50.0% in the fourth quarter. High Note Wealth LLC now owns 69 shares of the medical equipment provider's stock worth $39,000 after buying an additional 23 shares during the period. Finally, White Lighthouse Investment Management Inc. increased its stake in shares of Intuitive Surgical by 5.1% in the fourth quarter. White Lighthouse Investment Management Inc. now owns 473 shares of the medical equipment provider's stock worth $268,000 after buying an additional 23 shares during the period. Institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on ISRG shares. JPMorgan Chase & Co. dropped their price target on shares of Intuitive Surgical from $550.00 to $450.00 and set an "overweight" rating for the company in a research report on Friday, July 17th. Mizuho set a $500.00 price objective on shares of Intuitive Surgical and gave the company a "neutral" rating in a research report on Wednesday, July 15th. Citigroup lowered their price objective on shares of Intuitive Surgical from $590.00 to $500.00 and set a "buy" rating for the company in a research note on Friday, July 17th. Truist Financial dropped their target price on shares of Intuitive Surgical from $580.00 to $510.00 and set a "buy" rating for the company in a report on Thursday, July 16th. Finally, BTIG Research reiterated a "buy" rating and set a $469.00 target price on shares of Intuitive Surgical in a report on Tuesday. Twenty-two analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $508.68.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $360.46 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The firm's 50-day simple moving average is $377.41 and its two-hundred day simple moving average is $424.21. The stock has a market cap of $127.34 billion, a PE ratio of 41.29, a price-to-earnings-growth ratio of 2.67 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping analysts' consensus estimates of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to analysts' expectations of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business's revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.81 EPS. Equities research analysts predict that Intuitive Surgical, Inc. will post 8.85 EPS for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Mark Brosius sold 77 shares of the business's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $375.57, for a total value of $28,918.89. Following the sale, the executive vice president directly owned 881 shares of the company's stock, valued at approximately $330,877.17. The trade was a 8.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the sale, the executive vice president directly owned 5,320 shares in the company, valued at approximately $2,016,280. This represents a 6.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 11,256 shares of company stock worth $4,475,079 over the last three months. 0.60% of the stock is owned by corporate insiders.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: A meta-analysis found that da Vinci robotic-assisted surgery produced statistically significant improvements across 13 common benign conditions, including shorter hospital stays and faster returns to work versus laparoscopic and open surgery. The results reinforce the clinical value of Intuitive’s platform and could support further hospital adoption. Intuitive reports positive meta-analysis data
• Positive Sentiment: BTIG reiterated its Buy rating and set a $469 price target, signaling considerable potential upside. Broader analyst coverage remains favorable, with the stock described as trading at its cheapest valuation in roughly a decade. Recent earnings also showed strong execution, including 18.4% year-over-year revenue growth and an earnings beat. BTIG reiterates Buy rating
• Neutral Sentiment: Intuitive Surgical presented at the Wells Fargo Healthcare Conference. Investors are focused on management’s commentary regarding procedure trends, guidance, competition, costs and the long-term opportunity for robotic surgery. Wells Fargo Healthcare Conference transcript
• Neutral Sentiment: Reported short-interest data showed zero shares and a zero-day short-interest ratio, suggesting no measurable short positioning in the supplied data; however, the figures appear anomalous and should not be treated as a meaningful trading signal.
• Negative Sentiment: EVP Mark Brosius disclosed sales totaling 69 shares at approximately $350.20 and $361.23 under a pre-arranged Rule 10b5-1 plan. The transactions are small relative to his remaining holdings and are not necessarily bearish, but continued insider selling provides little additional support for the shares. Intuitive Surgical EVP stock sale
• Negative Sentiment: Investors remain concerned about slower U.S. procedure growth, rising costs, competitive pressure and the possibility that GLP-1 drugs could affect procedure volumes. Options markets also indicate that substantial volatility may persist after the stock’s steep decline from its 52-week high. ISRG volatility outlook

Intuitive Surgical Company Profile

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company's principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.